OMBLASTYS

Serial Number 88320059
Registration 5988020
700

Registration Progress

Application Filed
Feb 28, 2019
Under Examination
Dec 3, 2019
Approved for Publication
Oct 8, 2019
Published for Opposition
Oct 8, 2019
Registered
Feb 18, 2020

Attorney Assistance

Section 8 Declaration Due (Principal Register) (Based on registration date 20200218)
Due: Feb 18, 2026 50 days

Trademark Image

OMBLASTYS

Basic Information

Serial Number
88320059
Registration Number
5988020
Filing Date
February 28, 2019
Registration Date
February 18, 2020
Published for Opposition
October 8, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 18, 2020
Registration
Registered
Classes
005 042

Rights Holder

Y-mAbs Therapeutics, Inc

03
Address
230 Park Avenue, Suite 3350
New York, NY 10169

Ownership History

Y-mAbs Therapeutics, Inc

Original Applicant
03
New York, NY

Y-mAbs Therapeutics, Inc

Owner at Publication
03
New York, NY

Y-mAbs Therapeutics, Inc

Original Registrant
03
New York, NY

Legal Representation

Attorney
Andrew N. Spivak

USPTO Deadlines

Next Deadline
50 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20200218)
Due Date
February 18, 2026
Grace Period Ends
August 18, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

21 events
Date Code Type Description Documents
Feb 18, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Feb 18, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 15, 2020 DP1B I 1(B) BASIS DELETED; PROCEED TO REGISTRATION Loading...
Dec 5, 2019 IUCN S NOTICE OF ALLOWANCE CANCELLED Loading...
Jan 15, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 5, 2019 D1BR I TEAS DELETE 1(B) BASIS RECEIVED Loading...
Dec 3, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 8, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 8, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 18, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 3, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 24, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 24, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 24, 2019 ALIE A ASSIGNED TO LIE Loading...
Aug 15, 2019 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
May 10, 2019 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
May 10, 2019 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
May 10, 2019 CNSL R SUSPENSION LETTER WRITTEN Loading...
May 9, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 20, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 4, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer
Class 042
Research and development services in the field of antibodies; research and development services in the field of antibody technology; laboratory research and analysis services relating to the production of antibodies; scientific and technological services, namely, scientific research, analysis, and testing in the field of antibodies, and research and design relating thereto; industrial analysis and research services in the field of antibodies

Classification

International Classes
005 042